Pluto Bioinformatics

GSE119290: Expression-based drug screening of neural progenitor cells from individuals with schizophrenia [RNA-seq]

Bulk RNA sequencing

Integration of in silico and in vitro approaches to design and conduct transcriptomic drug screening in patient-derived neural cells, in order to survey novel pathologies and points of intervention in schizophrenia. SOURCE: Ben Readhead (ben.readhead@mssm.edu) - Icahn School of Medicine at Mount Sinai